Morrow, M. P., Gillespie, E., Sylvester, A., Amin, M. R., Belafsky, P. C., Best, S. R., Friedman, A. D., Klein, A. M., Lott, D. G., Mau, T., Paniello, R. C., Pransky, S. M., Saba, N. F., Tan, G. S., Wisotsky, S., Marcus, S. A., Reuschel, E. L., Reed, K. S., Weiner, D. B., Dallas, M., Skolnik, J. M. (2025). DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107. Nature Communications. https://doi.org/10.1038/s41467-025-56729-6